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The Transcription Factor GATA-3 Is Necessary
and Sufficient for Th2 Cytokine Gene
Expression in CD4 T Cells
Wei-ping Zheng and Richard A. Flavell* IL-4, respectively (Seder et al., 1992, 1993; Hsieh et al.,
1993; Kopf et al., 1993). IL-12 induces phosphorylationSection of Immunobiology
of Stat-4 in developing and differentiated Th1 cells butHoward Hughes Medical Institute
not in Th2 cells (Bacon et al., 1995; Jacobson et al.,Yale University School of Medicine
1995; Szabo et al., 1995) and IL-4 activates Stat-6 inNew Haven, Connecticut 06520-8011
Th2 cells (Hou et al., 1994; Schindler et al., 1994). The
activation of these two Stat proteins is essential for CD4
T cell subset development because Stat-4- or Stat-6-Summary
deficient mice are unable to generate Th1 and Th2 re-
sponses, respectively (Kaplan et al., 1996a; ThierfelderCD4 T cells potentiate the inflammatory or humoral
et al., 1996).immune response through the action of Th1 and Th2
The molecular mechanisms by which antigen stimula-cells, respectively. The molecular basis of the differen-
tion via T cell receptor (TCR) and cytokine signalingtiation of these cells from naive T cell precursors is,
integrate to drive Th1 and Th2 effector cell differentiationhowever, unclear. We found that GATA-3 was selec-
are, however, poorly understood. The intracellular re-tively expressed in Th2 cells. GATA-3 is expressed at
lease of Ca21 and activation of protein kinase C (PKC)a high level in naive, freshly activated T cells and Th2
induced by antigen stimulation via TCR induce the NF-lineage cells, but subsides to a minimal level in Th1
AT and AP-1 transcription activities (Rao, 1994; Rao,lineage cells as naive cells commit to their Th subset.
1991). Activation of the IL-2 and IL-4 promoters requiresAntisense GATA-3 inhibited the expression of all Th2
the coordinated binding of NF-AT and AP-1 to the NF-cytokine genes in the Th2 clone D10. GATA-3 directly
AT/AP-1 composite sites in the promoters (Rooney etactivated an IL-4 promoter-luciferase reporter gene in
al., 1995). However, since the IL-2 and IL-4 NF-AT/AP-1M12 cells. In transgenic mice, elevated GATA-3 in CD4
composite sites are interchangeable without affectingT cells caused Th2 cytokine gene expression in devel-
the Th1/Th2 specificity of the promoters, it is likely thatoping Th1 cells. Thus, GATA-3 is necessary and suffi-
other transcription factors are responsible for determin-cient for Th2 cytokine gene expression.
ing promoter specificity (Rooney et al., 1995). AP-1 and
NFAT are selectively activated in Th2 effector cells butIntroduction
show no difference in developing precursors, arguing
that their selectivity relates to effector cytokines ratherThe discovery of the Th1 and Th2 subsets of CD4 T
than the differentiation mechanism (RincoÂn et al., 1997b,cells in both mouse and human (Mosmann et al., 1986;
1997c). One possibility to explain specificity is thatRomagnani, 1991) has provided the cellular basis for
Stat-4 and Stat-6 may directly regulate the specificitythe diversity of T cell±dependent immune responses.
of the cytokine gene promoters in Th1 and Th2 cells.Th1 cells produce IFN-g, LTa (TNFb), and IL-2 and pro-
However, while the activation of Stat-4 in Th1 effector
mote the inflammatory and cellular immune response.
cells requires IL-12 treatment (Szabo et al., 1995), IL-12
In contrast, Th2 cells produce IL-4, IL-5, IL-6, IL-10, and
is not needed for the antigen-stimulated expression of
IL-13 and induce humoral immunity. In the course of
Th1 cytokines (Magram et al., 1996). In contrast, in Th2
infection and in pathologic conditions such as allergic
effector cells, antigen stimulation alone does activate
and autoimmune diseases (Romagnani, 1994; Abbas et
Stat-6, but this activation appears to be a secondary
al., 1996) polarized Th1 and Th2 responses are found
autocrine effect of IL-4 (Lederer et al., 1996). Further-
and are believed to be critical to the outcome of these more, activation of Stat proteins is a transient event that
conditions. Therefore, understanding the mechanisms
occurs rapidly upon stimulation, whereas the develop-
of development of Th1 and Th2 responses should give
ment of effector T helper cells takes several days (Abbas
insight into the pathogenesis and treatment of a variety
et al., 1996). Therefore, while it is apparent that Stats
of diseases. are essential early signal transducers in Th subset differ-
The effector immune response results from the differ- entiation, they are unlikely to determine the Th pheno-
entiation of naive CD4 T cells to Th1 or Th2 cells. This type directly. An alternative scenario of Th differentiation
appears to be a multistep process, in which naive T cells is that Stat activation and TCR signaling initiate a cas-
may pass through an intermediate stage at which both cade of changes of gene expression that ultimately
Th1 and Th2 cytokines are produced (Abehsira-Amar et leads to the development of effector phenotypes of Th1
al., 1992; Kamogawa et al., 1993; Lederer et al., 1996; and Th2 cells.
Nakamura et al., 1997). An individual naive CD4 T cell In support of the second model, two transcription
can differentiate into either Th1 or Th2 cells (Abehsira- factors preferentially expressed in Th2 cells have been
Amar et al., 1992; Rocken et al., 1992; Kamogawa et al., found to activate the IL-4 gene promoter. First, the pro-
1993). The differentiation pathway followed is deter- tein encoded by the proto-oncogene c-maf induced en-
mined by the environment in which the naive T cells dogenous IL-4 production when cotransfected with the
react to antigen stimulation. The most potent factors TCR-inducible NF-ATp into the B cell lymphoma M12
that influence Th1 and Th2 differentiation are IL-12 and (Ho et al., 1996), indicating a cooperative role of these
two factors. The transcription of the IL-4 gene can be
further enhanced by a newly identified factor, NIP45*To whom correspondence should be addressed.
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(Hodge et al., 1996). Second, the transcription factor
NF-IL6 was also found to berequired for the activation of
the human IL-4 promoter in a Th2 clone, via the positive
regulatory element 1 (PRE-1) of thehuman IL-4 promoter
(Davydov et al., 1995). However, the selective expres-
sion of these two transcription factors was observed in
fully differentiated Th2 cells. Their roles in thedifferentia-
tion of Th2 cells from naive precursors are less clear.
In addition, the regulation of the expression of other
Th2 cytokine genes by these factors has not yet been
demonstrated. Therefore, although much has been
known about the regulation of the IL-4 gene promoter,
our knowledge on the molecular mechanisms leading
to the development of the Th2 phenotype remains lim-
ited. We have recently shown that IL-6, which activates
NF-IL6, can stimulate IL-4 production by CD4 T cells,
providing a mechanism whereby APC could direct Th2
differentiation through the NF-IL6 family (RincoÂ n et al.,
1997a).
In the present study, we reasoned that developing Figure 1. cDNA Representational Analysis of Gene Expression in
Th1 and Th2 cells should express different sets of genes, Th2 Cells
some of which might direct the development of these (A) Naive CD4 T cells from B10A.5R pigeon cytochrome c TCR
cells from naive precursors. To identify these genes, we transgenic mice (Kaye et al., 1989) were induced to differentiate into
Th1 and Th2 cells for 4 days. cDNA was derived from these cellsperformed cDNA subtraction by representational differ-
and used for RDA with Th2 representations as the ªtestersº and theence analysis (RDA) (Lisitsyn et al., 1993; Hubank and
Th1 representations as the ªdrivers.º The original representationsSchatz, 1994) between normal Th1 and Th2 cells in-
and the difference products are shown. The faster migration of the
duced in vitro. We found that the transcription factor drivers is due to the removal of the linkers.
GATA-3 was the dominant species that was present (B) The testers, drivers, and the difference products were blotted
in the RDA cDNA difference products, and that it was and hybridized with a probe made from a 700 bp HindIII/BamHII
g-actin cDNA fragment (Gunning et al., 1983).selectively expressed in differentiating and effector Th2
(C) A second blot was prepared and hybridized with probe from acells. Strikingly, GATA-3 is required for the transcription
full-length murine GATA-3 cDNA (Ko et al., 1991).of all Th2 cytokine genes, and the loss of Th2 cytokine
(D) RT±PCR analysis of GATA-3 gene expression in the Th1 clone
gene expression in Th1 cells is at least in part a conse- AE7 and Th2 clone D10. Resting cells were stimulatedwith antigen (5
quence of the down-regulation of GATA-3. mg/ml pigeon cytochrome c peptide for AE7 and 1 mg/ml conalbumin
peptide for D10) and AKR/J APC for 20 hr.
Results
Th2 cells, a Th2 cDNA library was constructed and
screened with the third difference products (Dp3) asRDA Shows That GATA-3 Is Selectively
Expressed in Th2 Cells probes. After screening 7.5 3 105 recombinant colonies,
165 positive signals were identified, of which 67 (40.6%)To identify Th2-specific genes, we performed cDNA
RDA (Hubank and Schatz, 1994) between Th2 and Th1 were found to be identical to the transcription factor
GATA-3 (Ko et al., 1991) by DNA sequencing.cells (Figure 1). Representations (see Experimental Pro-
cedures) of Th1 and Th2 cDNA were prepared from To confirm that GATA-3 is preferentially expressed by
Th2 cells, probes were made from GATA-3 cDNA andcDNA derived from Th1 and Th2 effector cells. RDA was
performed with theTh2 representations as``testers'' and hybridized to the original Th1 and Th2 representations
and to the Th2 RDA difference products (Figure 1C).an excess amount of Th1 representations as ``drivers.''
After one round of subtraction, the first difference prod- Strong signals were detected in original Th2 representa-
tions with only a very weak band being detected in Th1ucts (Dp1) showed some discrete bands. After subse-
quent subtractions, bands became more clear in the representations. The GATA-3 signals became stronger
after each subtraction, indicating that the fragments ofdifference products, and no polydisperse DNAs were
seen after three rounds of subtraction (Figure 1A). To this gene had been enriched. As in normal T cells, strong
expression of GATA-3 was detected by RT±PCR in ashow that genes common to both Th1 and Th2 cells
were successfully subtracted, the DNA was Southern Th2 clone D10 but only minimal expression in a Th1
clone AE7 (Figure 1D).analyzed and hybridized to g-actin probes (Figure 1B).
The lowest band of g-actin almost disappeared even
after only one subtraction. After three rounds of subtrac- Kinetics of GATA-3 Expression during In Vitro
Differentiation of Th1 and Th2 Cells Correlatestion, no g-actin signals were detectable, demonstrating
that subtraction was successful. Since the RDA prod- with Subset Commitment
GATA-3 belongs to the GATA family of zinc finger pro-ucts were small cDNA fragments of different genes, it
was unproductive to recover all the genes represented teins. Many members of this gene family function as reg-
ulators of cellular differentiation. For example, GATA-1in the final difference products by random cloning of
the difference products. To overcome this problem and and GATA-4 are involved in erythrocyte and cardiac
muscle cell development, respectively (Pevny et al.,identify the full-length genes differentially expressed in
Differentiation of Th1 and Th2 Cells
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Figure 3. Reduction of GATA-3 Protein in Antisense GATA-3
Transfectants
The transfectants were stimulated with APC and conalbumin pep-
tide (1 mg/ml), and labeled with 35S-methionine overnight. Equal
number of cells were harvested for immunoprecipitation. GATA-3
proteins were captured by anti-GATA-3 mAb HG3±31 conjugated
to agarose beads. Proteins were separated in a 12% polyacrylamide
gel.Figure 2. Time Course of GATA-3 Gene Expression during In Vitro
Differentiation of CD4 T Cells
Naive (CD44lowCD45RBhigh) CD4 T cells from AKR/J mice were stimu-
Th2 cytokine genes. Since GATA-3 deficiency causeslated in vitro for differentiation. RNA was prepared at different time
embryonic lethality (Pandolfi et al., 1995) and GATA-32/2points for RT±PCR. HPRT was used as internal control to normalize
ES cells can not reconstitute the T cell compartment inthe PCR templates. IL-4 and IFN-g profiles are shown to indicate
the differentiation status of the stimulated cells. RAG-2-deficient mice (Ting et al., 1996), we sought to
study the role of GATA-3 in regulating Th2 cytokine gene
expression by expressing an antisense GATA-3 con-
struct in the Th2 clone D10. Two separate stable lines1991; Grepin et al., 1995). Therefore, we considered that
GATA-3 may function in a similar way to determine the of anti-GATA-3 transfectants, D10.3.4.1 and D10.3.4.2,
were established from two independent transfections.differentiation of Th2 cells. We approached this question
by first examining the time course of GATA-3 expression GATA-3 expression was significantly reduced in both
lines with the expression in D10.3.4.2 cells slightly higheras Th1 and Th2 cells differentiated in vitro (Figure 2).
Consistent with a previous report that GATA-3 is ex- than in D10.3.4.1 cells (Figure 3). As shown in Figure
4A, compared with the control transfectant D10.3, thepressed in mature CD4 thymocytes (George et al., 1994),
we found that GATA-3 is also expressed in peripheral expression of IL-4, IL-6, and IL-13 mRNA in D10.3.4.1
cells was abolished and the expression of IL-10 mRNAnaive CD4 T cells. The level of expression was not al-
tered after activation for one day using priming condi- was also greatly inhibited. IL-5 gene expression was
apparently also inhibited, albeit to a lesser extent. Intions for either Th1 or Th2 cells. However, while the
expression level of GATA-3 remained at a high level the second transfected line D10.3.4.2 (Figure 4B), ex-
pression of the IL-6 and IL-13 genes was also ablatedduring the entire time course of differentiation to Th2
cells, it was dramatically decreased after 2 days of prim- by the antisense GATA-3, and IL-4 message was greatly
reduced but still weakly detectable. Just as in D10.3.4.1ing for the Th1 response and remained at this low level
in the Th1 lineage cells (Figure 2). To confirm the differ- cells, IL-10 mRNA was also significantly reduced in
this line, while inhibition of IL-5 mRNA was not demon-entiation status of the in vitro±primed Th1 and Th2 cells,
the cytokine mRNA expression patterns were analyzed strable. The Th1 cytokine IFN-g was not expressed (Fig-
ures 4A and 4B), and the lineage-nonspecific IL-3 wasby RT±PCR. In agreement with previous studies (Lederer
et al., 1996; Nakamura et al., 1997), low levels of both equally expressed weakly in all three D10 lines (Figures
4A and 4B).IL-4 and IFN-g mRNA were detected after 1 day of prim-
ing for both Th1 and Th2 responses. Strong and skewed To quantitate the extent of inhibition of cytokine gene
expression, we performed competitive RT±PCR (Reinerexpression of these two cytokine genes was observed
after 2 days of priming, by which time GATA-3 expres- et al., 1994). Antisense GATA-3 reduced IL-4 mRNA to
undetectable levels in D10.3.4.1 cells and by 86% insion differed radically in these two populations, confirm-
ing that after 2 days, CD4 T cells have completed their D10.3.4.2 cells and IL-10 message by 87% and 75%,
respectively, in these two cell lines. The effect on IL-5ªcommitmentº to the Th1 or Th2 lineages. For a detailed
analysis of this issue see Nakamura et al. (1997). The message was modest, being insignificant for D10.3.4.2
cells and 16% inhibition in D10.3.4.1 cells. IL-6 mRNAkinetics of GATA-3 expression, therefore, correlated
with the time course of Th1 and Th2 differentiation, was completely eliminated in both cell lines.
Similar inhibitory effects of antisense GATA-3 on thewhich suggested that the regulation of GATA-3 expres-
sion may be a crucial event in the differentiation of CD4 levels of IL-4, -5, -6, and -10 in the supernatants of
these transfectants were observed by ELISA (Figure 4D).T cell subsets.
Taken together, these data show that GATA-3 must be
expressed above a threshold level to maintain the Th2GATA-3 Is Required to Maintain the Th2 Phenotype
in the Prototypic Th2 Clone D10 phenotype in differentiated Th2 cells.
The stable expression of GATA-3 in the Th2 lineage
suggested that it may play a role in Th2 cytokine gene Antisense GATA-3 Transfectants Express Normal
Level of TCR but Proliferate at Lower Ratesexpression. In support of this notion, EL-4 and Jurkat
cells, from which murine and human GATA-3 were in Response to Antigen Stimulation
GATA-3 binding sites have been found in the TCR d andcloned, respectively, produce IL-4 and other Th2 cyto-
kines (Klein et al., 1995; Lee et al., 1994), and potential a gene enhancers and GATA-3 can transactivate these
enhancers (Ko et al., 1991; Ho et al., 1993). To rule out theGATA-3 binding sites are present in the promoters of all
Cell
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Figure 4. RT±PCR Analysis of Cytokine Gene
Expression in D10 Transfectants
The transfectants were rested for 10±12 days
after the last antigen stimulation and restimu-
lated for 18±20 hr.
(A and B) Direct comparison between con-
trol D10.3 (lanes of odd numbers) and anti-
sense GATA-3 transfectants, D10.3.4.1 (A) or
D10.3.4.2 (B) (lanes of even numbers).
(C) Competitive PCR (Reiner et al., 1994) for
semiquantitation of cytokine gene expres-
sion. The numbers on the top of each panel
represent the amount of competitive DNA
used in the PCR. The amount of competitive
cDNA that gave rise to the same intensity as
the wild-type bands is shown in bold.
(D) Cytokine level in the supernatants of the
transfectants. Column 1: D10.3; 2: D10.3.4.1;
3: D10.3.4.2.
possibility that the inhibition of cytokine transcription in both D10.3.4.1 and D10.3.4.2 cells could respond to
antigen stimulation as judged by proliferation (Figurethe antisense GATA-3 transfectants was due to inade-
quate stimulation of the cellscaused by low TCR expres- 5B). However, the proliferation rates were consistently
somewhat lower than the control transfectants. This de-sion, TCR levels were analyzed by flow cytometry. The
cells were stained with the clonotypic mAb 3D3, which creased proliferation seems to be a secondary effect of
the lack of autocrine IL-4 or other growth factors, be-recognizes both chains of the D10 TCR (Kaye et al.,
1983). As shown in Figure 5A, TCR expression levels cause addition of culture supernatant from normal D10
cells could restore the growth of the antisense transfec-were not altered in the antisense GATA-3 transfectants
as compared with that of the control D10.3 cells. In fact, tants (data not shown). The inhibition of cytokine gene
Figure 5. The Effect of Antisense GATA-3 on
TCR Expression and Cell Proliferation
(A) The control D10.3 or antisense D10.3.4.1
and D103.4.2 cells were first incubated with
the clonotypic mAb 3D3 (Kaye et al., 1983),
then stained with anti-CD4-PE and FITC-con-
jugated goat anti-mouse IgG. CD41 cells
were gated for flow cytometry analysis. The
closed histograms show the TCR expression
level. Open histograms are the negative con-
trols (stained with FITC-conjugated goat anti-
mouse IgG only).
(B) Proliferation assay was done as described
in the Experimental Procedures. The incorpo-
ration of [3H]thymidine of both stimulated
(shaded columns) and unstimulated (stippled
columns) cells are shown.
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CD42CD81, and CD42CD82) and spleen cells (B cells,
CD4 and CD8 T cells) (data not shown).
Naive CD4 T cells from the transgene-positive animals
and negative littermates were differentiated in vitro to
the Th1 subset by culturing in ConA plus IL-2, IL-12,
and anti-IL-4 mAb for 3 days, a time at which the Th1
phenotype is fully manifested at the mRNA level in this
system (Kamogawa et al., 1993; Nakamura et al., 1997;
Figure 6. GATA-3 Transactivates the IL-4 Promoter in M12 B Cell RincoÂ n and Flavell, 1997). Interestingly, we found that
Lymphoma the cells from transgenic mice grew slower than
The IL-4 promoter reporter plasmid (p-157IL4luc) was cotrans- transgene-negative cells (Figure 7C). By day 3, there
fected into M12 cells with or without a GATA-3 expression vector
was an approximately 2-fold difference in the number(R/mGATA-3). One day later, the cells were treated with PMA and
of cells between the transgene-positive and -negativeionomycin (PI) or left untreated as indicated for 24 hr. Cell extracts
littermates. Consistent with our previous observations,were measured for luciferase activities. Fold induction was shown
as compared to the unstimulated (p-157IL4luc) cells. only low levels of GATA-3 were present in the non-
transgenic Th1 precursors (Figure 7D). GATA-3 expres-
sion was, however, greatly elevated in the transgenic
samples. The higher expression of GATA-3 in Th1 pre-expression in D10 cells by antisense GATA-3 is therefore
cursors of line 25 than those of line 3 correlated withspecific rather than a secondary result of the reduced
their expression levels of the transgene in resting T cellscapability to respond to antigen stimulation.
(Figure 7B). The same large amount of IFN-g mRNA
was detected in the Th1 precursors of both transgene-
Ectopic Expression of GATA-3 Activates the IL-4
positive and -negative mice. In contrast, while no IL-4
Promoter in B Cell Lymphoma M12
mRNA was detectable in the nontransgenic developing
To determine whether GATA-3 can directly transactivate
Th1 cells as expected, IL-4 mRNA was detectable in the
the IL-4 promoter, we constructed a reporter plasmid
transgenic samples with the level in line 25 being higher
in which the firefly luciferase gene was driven by the
than in line 3. Likewise, IL-6 mRNA was barely detect-
2157 to 168 region of IL-4 promoter (Todd et al., 1993;
able in the nontransgenic developing Th1 cells, but was
Hodge et al., 1995; Rooney et al., 1995). A GATA-3 ex-
detected at high level in transgenic line 25 and (to a
pression vector and the reporter construct were
somewhat lesser extent) in line 3. IL-5 and IL-10 were
cotransferred into the B cell lymphoma M12, which does
detected at low levels in the nontransgenic samples.
not express either GATA-3 or IL-4 genes. The induction
A large increase in IL-10 mRNA was observed in the
of the luciferase activity in M12 cells was minimal with
transgenic samples with a greater increase in line 25
or without stimulation with PMA plus ionomycin in the
than in line 3. IL-5 mRNA was increased in both
absence of GATA-3 (Figure 6). GATA-3 alone did not
transgenic lines although the effect was less dramatic
activate the IL-4 promoter in unstimulated cells. A dra-
than the effect on IL-4, 6, and 10, consistent with our
matic induction of luciferase activity was, however, ob-
antisense data in D10 cells (Figure 4). The same results
served when the cells were treated with PMA plus iono-
were obtained with a third transgenic line. However, IL-
mycin in the presence of GATA-3. GATA-3 appears
13 mRNA remained undetectable in both transgene-
therefore to be a potent transactivator of the IL-4 pro-
positive and -negative cells. The expression of lineage-
moter.
nonspecific IL-3 was not affected by the GATA-3
transgene (Figure 7D). Thus, ectopic expression of
Constitutive Expression of GATA-3 Causes Th2 GATA-3 in developing Th1 cells causes the abnormal
Cytokine Gene Expression in Th1 Precursors expression of all the Th2 cytokine genes.
of CD4-GATA-3 Transgenic Mice
The observation that GATA-3 expression was signifi-
cantly down-regulated at the same time that naive T Discussion
cells appeared to commit to the Th1 subset led us to
speculate that the loss of Th2 cytokine expression in Th1 The molecular mechanisms underlyingCD4 T cellsubset
differentiation have been under intensive study. For Th2cells is caused by the reduced expression of GATA-3.
To test this, we generated GATA-3 transgenic mice in subset differentiation, much work has focused on the
regulation of IL-4 gene expression. In this study, wewhich GATA-3 expression was driven by the CD4 pro-
moter (Killeen et al., 1993) (Figure 7A). The expression have identified the transcription factor GATA-3 to be
necessary for the transcription of all the Th2 cytokineof the GATA-3 transgene in peripheral T cells was veri-
fied by RT±PCR (Figure 7B) using a 59 primer derived genes that we have tested in CD4 T cells. We have
also shown that forced expression of GATA-3 in Th1from the sequence of the first exon of the CD4 gene
and the 39 primer derived from the 59 end of the GATA-3 precursors is sufficient to alter the course of Th1 subset
differentiation and that this causes abnormal expressioncDNA. Of the two transgenic lines used in this study,
the level of transgene expression in line 25 was higher of these same Th2 cytokine genes in these cells. Unlike
most prior studies, which took the approach of analyzingthan in line 3 (Figure 7B). Overexpression of GATA-3 did
not have any overt effects on lymphocyte development specific promoter elements and their trans-activating
factors, ourstudy was based on a more general assump-since both transgenic lines had normal profiles of
thymocyte subpopulations (CD41CD81, CD41CD82, tion that different sets of regulatory genes are utilized
Cell
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Figure 7. The Generation and Characteriza-
tion of CD4-GATA-3 Transgenic Mice
(A) Schematic representation of the CD4-
GATA-3 construct. The single line represents
the modified first intron of the CD4 gene.
Shaded boxes represent the first and second
exons of CD4 gene. The open box represents
the full-length murine GATA-3 cDNA. The po-
sitions of the probes used for screening
transgene-positive mice and the primers for
RT±PCR analysis of the expression of the
transgene are also shown.
(B) RT±PCR was performed using the primers
indicated in (A) to show the spliced mRNA
species of the transgene.
(C and D) Naive CD4 T cells from transgene-
negative (column/lanes 1 and 2) and -positive
(column/lanes 3 and 4) littermates of line 25
and 3, respectively, were induced to differen-
tiate in vitro to the Th1 subset for 3 days
with ConA, IL-2, IL-12, and anti-IL-4 mAb. Cell
number difference (C) and the expression of
GATA-3 and cytokine genes (D) are shown.
by the differentiating and/or differentiated Th2 versus GATA-3. Such a pattern of high versus low expression
in Th2 and Th1 cells, respectively, indicated that a rela-Th1 cells. While this strategy could miss posttranscrip-
tional events that might play important roles in differenti- tively high level of GATA-3 is required for Th2 cytokine
gene expression. To test this, we generated antisenseation, any process that leads to a difference in the steady
state level of a given mRNA can be studied. We therefore GATA-3 lines from D10 cells and showed that the tran-
scription of all Th2 cytokine genes in these two linesembarked on the search for genes differentially ex-
pressed in Th2 cells by cDNA subtraction between Th2 was inhibited as a result of the decreased expression
of GATA-3. Thus, a high level of GATA-3 is required forand Th1 cells using RDA (Lisitsyn et al., 1993; Hubank
and Schatz, 1994). We found that the transcription factor Th2 cytokine gene expression. Generally, GATA factors
share highest homology in their DNA binding motifs (Ya-GATA-3 is the most predominant gene species selec-
tively expressed in Th2 cells. mamoto et al., 1990), so that different GATA factors often
recognize overlapping DNA sequences. Consequently,The time point we chose for RDA was 4 days after in
vitro induction of Th1 and Th2 subsets from naive CD4 the functional specificity of a particular GATA factor is
achieved through specific expression in its host cells.T cells. Although it is possible that genes turned on/off
at earlier time points may be missing in the original cDNA Accordingly, selective expression of GATA-3 in Th2 cells
is important for this transcription factor to be able topools, in this particular case, the striking difference in
the expression of GATA-3 in Th1 and Th2 cells was function as the specific regulator of Th2 cell differentia-
tion. However, it remains unclear why a low level ofalready manifest by both day 2 and day 3 after primary
stimulation. Specifically, in Th1 cells, GATA-3 expres- GATA-3 is maintained in Th1 cells. Since GATA-3 is
essential for T cell development (Hattori et al., 1996;sion was dramatically down-regulated on day 2 after
stimulation. This change in GATA-3 expression corre- Ting et al., 1996), a basal level of GATA-3 is perhaps
required for maintaining the T cell status of the Th1 cells,lated with the polarized expression of IFN-g and the loss
of IL-4 expression and, hence, with the susceptibility of for example, by maintaining TCR expression (Ko et al.,
1991; Ho et al., 1993).the Th1 subset from IL-4-TK transgenic mice to killing
by gancyclovir (Kamogawa et al., 1993; Nakamura et al., In trying to understand the mechanisms by which
GATA-3 regulates Th2 cytokine gene expression, we1997). In other words, GATA-3 expression drops as Th1
cells ªcommitº to their lineage, suggesting that the loss searched the genomic sequences of all Th2 cytokine
genes for potential GATA-3 binding sites. We found thatof Th2 cytokine gene expression in Th1 cells is due to
the diminished expression of GATA-3. Down-regulation GATA-3 binding sites are present in the promoter re-
gions of all Th2 cytokine genes, suggesting that GATA-3of a particular transcription factor has been observed
to be key to the differentiation of other hemopoietic may directly activate these promoters. We confirmed
this by showing that GATA-3 can activate the IL-4 pro-lineages. For example, the CCAAT/enhancer binding
protein C/EBPa is expressed at high level in myeloblasts moter in the B cell lymphoma M12. Unlike c-Maf, GATA-3
alone did not seem to activate the IL-4 promoter inbut diminishes to low level in their terminal differentiation
into polymorphonuclear cells (Scott et al., 1992). M12 cells without stimulation with PMA plus ionomycin,
indicating that GATA-3 must act in cooperation withLike the in vitro±induced Th2 cells, the long-term Th2
clone D10 also expressed a high level of GATA-3 in other activation-inducible factors such as AP-1 and NF-
AT to activate the IL-4 promoter. In a different study, itcontrast to the Th1 clone AE7, which expressed low
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Figure 8. Schematic Illustration of the Differ-
entiation Process of CD4 T Cell Subsets
(A) A general model for Th1 and Th2 cell de-
velopment.
(B) Molecular events during Th2 differenti-
ation.
was found that GATA-3 can also directly transactivate 1996). Thus, it is reasonable to assume that other factors
required for Th1 cytokine gene expression must bepres-the IL-5 promoter (D.-H. Zhang et al., submitted). It is
also noteworthy that the susceptibility to inhibition by ent in the Th1 lineage but are lost during Th2 subset
development just as GATA-3 is lost in Th1 cells (Figureantisense GATA-3 was different among the Th2 cytokine
genes. Given the fact that GATA-3 can directly act on 8A). This hypothesis is further supported by our finding
that, in the antisense GATA-3 transfectants, no IFN-gat least two (IL-4 and IL-5), and probably all, of the Th2
cytokine gene promoters, the difference in susceptibility mRNA was induced (Figures 4Aand 4B), and it is consis-
tent with our previous general model for Th differentia-may reflect the difference in binding affinity of the
GATA-3 sites in different Th2 cytokine genes. In other tion (Kamogawa et al., 1993; Nakamura et al., 1997).
The IL-4 gene is expressed at a lower level in thewords, the expression of different Th2 cytokine genes
requires a different threshold of GATA-3. Based on anti- GATA-3 transgenic Th1 precursors than in effector Th2
cells, perhaps because other transcription factors suchsense inhibition and induction by GATA-3 elevation in
transgenic mice, the level of GATA-3 required for differ- as c-Maf (Ho et al., 1996) are required for optimal expres-
sion of the IL-4 gene in CD4 T cells. c-Maf is not detect-ent cytokine expression can be tentatively listed as
IL-13.IL-6.IL-4.IL-10.IL-5. Obviously, the possibility able in developing Th2 cells but accumulates when Th2
effector cells have ªcompletedº their differentiation (Hocannot be excluded that the relatively high level of the
remaining expression of IL-5 and IL-10 in the antisense et al., 1996). In addition, other differences in transcrip-
tion regulation between Th1 and Th2 cells also exist,transfectants is due to an alternative mechanism inde-
pendent of GATA-3. Nevertheless, the differential re- which may be important for optimal Th2 cytokine gene
expression. For example, we found that AP-1 and NF-quirement of GATA-3 for Th2 cytokine gene expression
provides a potential explanation for the existence of AT were preferentially activated in Th2 rather than Th1
effector cells (RincoÂ n et al., 1997b), and JunB (RincoÂnintermediate CD4 T cells, between Th1 and Th2 ex-
tremes, that express different sets of cytokines (for re- et al., 1997b; Rooney et al., 1995) and JunD (Rooney et
al., 1995) of the AP-1 complex were selectively ex-view, see Mosmann and Sad, 1996).
To test if GATA-3 could divert the differentiation pro- pressed in Th2 cells. Because GATA-3 transactivation in
M12 cells requires stimulation with PMA and ionomycingram of Th1 precursors to a Th2 program, transgenic
mice were made where GATA-3 expression was driven (Figure 6), which likely activateNF-AT and AP-1, GATA-3
may also synergize with these factors to induce IL-4in both subsets by the CD4 promoter (Killeen et al.,
1993). After stimulation under priming condition for the gene expression in Th2 cells. In Th1 cells where these
additional factors may be less readily available (RincoÂnTh1 subset, the developing ªTh1º population from the
transgenic mice now expressed all Th2 cytokine genes et al., 1997a, 1997b), increased level of GATA-3 may
therefore only induce suboptimal expression of IL-4except IL-13. These data, together with the down-regu-
lation of GATA-3 in committed Th1 cells, demonstrate gene. Alternatively, IFN-g produced by the transgenic
CD4 T cells could specifically inhibit the expression ofthat the loss of Th2 cytokine gene expression in Th1
cells is at least in part due to their diminished GATA-3 the IL-4 gene. Nevertheless, collectively, the data sug-
gest that the differentiation of the Th2 subset may followexpression. However, the forced expression of GATA-3
did not abort the program for Th1 cytokine gene expres- a model inwhich transcription factors cooperate in com-
bination to define a cell type as seen in the differentiationsion as seen by the unaltered expression of the IFN-g
gene. This is consistent with a previous finding that of many other hemopoietic lineages (Ness and Engel,
1994).hybrid cells derived from fusion of cloned Th1 and Th2
cells produced both Th1 and Th2 cytokines (Ho et al., To date, six transcription factors (Stat-6, c-Maf,
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repeated twice using different primers and tester:driver ratios ofNF-IL6, NF-AT, AP-1, and now GATA-3) have been impli-
1:800 and 1:400,000.cated in Th2 cell differentiation (Davydov et al., 1995;
Rooney et al., 1995; Ho et al., 1996; Kaplan et al., 1996b;
cDNA Library Construction and Screening
RincoÂ n et al., 1997b, 1997c). Precisely how these factors Total RNA was isolated from in vitro±differentiated Th2 cells. cDNA
interact remains to be elucidated. From the present synthesis and library construction were carried out using a ZAP
study and a previous study on APC-produced IL-6 in Express/Gigapack III Gold Cloning Kit (Stratagene).
The Th2 library was screened using Th2.Dp3or Th1.Dp3 as probesTh2 differentiation (RincoÂ n et al., 1997a), we believe that
at 5±10 3 106 cpm/ml. The screening was carried out in two steps.IL-6-activated members of the C/EBP family, such as
First, 2 3 104 colonies were plated in 20 150 mm dishes. Two sepa-NF-IL6 (Davydov et al., 1995), GATA-3 (expressed at
rate plate lifts were prepared and differentially hybridized to Th2.Dp3
high level in naive T cells), NF-AT, and AP-1 (Rooney et and Th1.Dp3 probes. The small number of colonies in each plate
al., 1995) initiate IL-4 production in early activated naive allowed the identification of single positive colonies without further
T cells (Croft and Swain, 1995). The secreted IL-4 in turn screenings. Typically, colonies hybridized to Th2.Dp3 do not hybrid-
ize to Th1.Dp3, and few colonies hybridize to Th1.Dp3. Phagemidsactivates Stat-6, which through an unkown mechanism
from Th2.Dp3-hybridizing colonies were pooled, and their cDNAmight, for example, maintain a high level expression of
inserts were recovered by a single restriction digestion and usedGATA-3. As precursor cells commit to the Th2 lineage,
as probes in the second step. In the second step, 7.5 3 105 colonies
high levels of c-Maf expression would be induced (Ho were screened with probes of Th2.Dp3 and the cDNA inserts recov-
et al., 1996), perhaps by mechanisms involving GATA-3, ered from the first step. Nonoverlapping colonies that hybridize to
to participate in high level expression of IL-4 and per- the Th2.Dp3 only were identified and further screened to obtain
single colonies. Phagemid DNA of the Th2-specific colonies of bothhaps other Th2 cytokine genes (Figure 8B). Obviously,
the first and second steps were sequenced using the 59 T3 primerthese speculations need to be confirmed by future ex-
on an ABI automated sequencer and further studied.periments.
Nevertheless, the present study shows that GATA-3
RT±PCR
appears to be a key regulator of the collective activity Total RNA was isolated from cultured cells using the Ultraspec RNA
of the transcription factors related to Th2 cytokine gene Isolation System-II (Biotecx). Reverse transcription was carried out
using Superscript II RT (GIBCO±BRL). The primers and PCR condi-expression. It could therefore be a major target for modi-
tions for HPRT and cytokine genes and competitive PCR were de-fying the immune responses in many immunological
scribed previously (Reiner et al., 1994). The same PCR conditionsconditions. From a pharmaceutical viewpoint, the fact
were used for the analysis of other genes. Sequences of other
that merely lowering rather than abolishing GATA-3 ex- primers used in this study are as following: GATA-3: GAAGGCAT
pression is sufficient to change the phenotype of the CCAGACCCGAAAC and ACCCATGGCGGTGACCATGC; b-tubulin:
CD4 effector cells may facilitate such intervention. ATGTT GCTCTCAGCCTCGGTGAAC and TGTCCATGAAGGAGGTG
GAT GAG; IL-3: ATACCCACCGTTTAACCAGAACG and GATCTCGA
ATGAAGACCCCTGGC; IL-6: GAACAACGATGATGCACTTGCAGExperimental Procedures
and CCTTAGCCACTCCTTCTGTGAC; IL-13: CCACTACGGTCTCCA
GCCTCC and TTGCCAGGCTGAGACCCTGAG; GM-CSF: GGCAATPreparation of Naive CD4 T Cells and APCs
TTC ACCAAACTCAAGGGC and CCAAGTTCCTGGCTCATTACGC.To isolate naive CD4 T cells, mice were kept in a clean environment
for at least two weeks prior to sacrifice. CD4 T cells were prepared
as described (Kamogawa et al., 1993). Naive (CD45RBhigh CD44low) Plasmids and Transgenic Mice
cells were sorted on a Becton Dickinson FACStar plus. To prepare Murine GATA-3 cDNA was a gift from Frank Grosveld and James
APCs, spleen cells were treated with mAb Y19, TIB105, GK1.5, and D. Engel. The full-length GATA-3 cDNA in pBlueScript SK was ex-
HB191 plus rabbit complement to remove T cells and NK cells, then cised by EcoRI digestion and blunt-ended with T4 DNA polymerase
g-irradiated with 3000 rad. I and cloned into the SalI site of plasmid CD4 promoter vector p37.1
(a gift of D. Littman), which expresses in both CD4 and CD8 T cells.
The ligation produced clones with GATA-3 in sense and antisenseIn Vitro Differentiation of CD4 T Cells
orientations with respect to the CD4 promoter. The CD4-GATA-3Naive CD4 T cells (5 3 105/ml) were incubated with an equal number
fragment was excised by NotI from the sense clone and used forof syngeneic APC in Bruff's medium containing 5% FCS, 2.5 mg/ml
construction of transgenic mice. The CD4-anti-GATA-3 fragmentCon A or 5 mg/ml pigeon cytochrome c peptide (in the case of
was excised by NotI and cloned into the NotI site of pcDNA3 (In-pigeon cytochrome c TCR transgenic CD4 T cells), and 25 units/ml
Vitrogen). A clone in which the CMV promoter of pcDNA3 and theIL-2. For the induction of Th1 cells, 3.5 ng/ml IL-12 and anti-IL-4
CD4 promoter were in the same orientation was used as the anti-mAb 11B11 were added to the culture; 1000 units/ml IL-4 and anti-
sense GATA-3 construct, pCD4aGATA3. The control plasmidIFN-g mAb XMG1.2 were used for the induction of Th2 cells. Cells
pcDNA3.CD4 was created by cloning the NotI CD4 promoter frag-were stimulated for various days and harvested for further analysis.
ment from p37.1 into pcDNA3 vector.
To make the IL-4 luciferase reporter construct pIL4±157Luc, thecDNA Representational Difference Analysis
2157 to 168 IL-4 promoter fragment in the IL-4 CAT construct (aRDA for cDNA was performed as described (Lisitsyn et al., 1993;
gift of L. Glimcher) was amplified by PCR with a 59 primer linked toHubank and Schatz, 1994). In brief, cDNA from the in vitro±induced
a HindIII adapter and a 39 primer linked to an NheI adapter. TheTh cells was digested with Dpn II and ligated to the R-Bgl-12/24
PCR fragments were digested with NheI and HindIII and cloned intoadapters. Representations were made by PCR amplification of the
the compatible sites of the luciferase plasmid pgl3 (Promega). TheR-ligated cDNA fragments for 20 cycles using the R-Bgl-24mer as
IL-4 promoter sequence in pIL4±157Luc was verified by sequencing.primer. The R-linker sequences in Th2 representations were re-
placed with J-Bgl-12/24 adaptors. First subtractive hybridization
was set up using 0.4 mg J-ligated Th2 representations as testers Cell Culture and Transfection
Normal T cells and clones were grown in Bruff's medium plus 5%and 80 mg linker-removed Th1 representations as ªdriversº
(tester:driver 5 1:100). An aliquot of the hybridization mixture was FBS. The Th1 clone AE7 was a gift of M. Lenardo and maintained
by stimulation with AKR/J APC plus pigeon cytochrome c peptideamplified by PCR for 10 cycles using the J-24mer as primers. The
PCR products were then digested with mung bean nuclease (New (5 mg/ml) and 30±50 units IL-2/ml every two weeks. The Th2 clone
D10 (a gift of C. A. Janeway, Jr.) were stimulated every 3±4 weeksEngland Biolabs) for 35 min at 308C. The digested PCR products
were further amplified for 18 cycles, and the products of this amplifi- with AKR/J APC and chicken conalbumin (Sigma) (100 mg/ml). The
B cell lymphoma M12 was cultured in RPMI 1640 plus 5% FCS.cation are the first difference products (Dp1). The procedure was
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Transfection of D10 cells and M12 cells was done essentially as of transcription factor GATA-4 expression blocks in vitro cardiac
muscle differentiation. Mol. Cell. Biol. 15, 4095±4102.described (Todd et al., 1993; Ho et al., 1996). To establish stable
transfectants, D10 cells transfected with pD4aGATA3 or pcDNA3. Gunning, P., Ponte, P., Okayama, H., Engel, J., Blau, H., and Kedes,
CD4 were allowed to recover for 48 hrs, then stimulated with antigen L. (1983). Isolation and characterization of full-length cDNA clones
plus APC in medium containing 800 mg/ml G418 (GIBCO±BRL). The for human alpha-, beta- and gamma-actin mRNAs: skeletal but not
cells were stimulated every 1±2 weeks. After selection in G418 for cytoplasmic actins have an amino terminal cystein that is subse-
4±5 weeks, stable G418-resistant lines were established. Three quently removed. Mol. Cell. Biol. 3, 787±795.
independent transfections generated the stable antisense lines Hattori, N., Kawamoto, H., Fujimoto, S., Kuno, K., and Katsura, Y.
D10.3.4.1 and D10.3.4.2 and the control line D10.3. The cell lines (1996). Involvement of transcription factors TCF-1 and GATA-3 in
were maintained in medium containing 200 mg/ml G418. the initiation of the earliest step of T cell development in the thymus.
J. Exp. Med. 184, 1137±1147.
Immunoprecipitation Ho, I.-C., Vorhees, P., Marin, N., Karpinski Oakley, B., Tsai, S.-F.,
D10 transfectants were stimulated with AKR/J APC and conalbumin Orkin, S.H., and Leiden, J.M. (1993). Human GATA-3: a lineage-
peptide (1 mg/ml) and labeled with 0.2 mCi/ml 35S-methionine over- restricted transcription factor that regulates the expression of the
night. Cells were lysed and GATA-3 proteins were captured by aga- T cell receptor a gene. EMBO J. 10, 1187±1191.
rose beads conjugated with anti-GATA-3 mAb HG3±31 (Santa Cruz
Ho, I.-C., Hodge, M.R., Rooney, J.W., and Glimcher, L.H. (1996). TheBiotechnology) according to the manufacturer's instructions.
proto-oncogene c-maf is responsible for tissue-specific expression
of interleukin-4. Cell 85, 973±983.
Proliferation Assay
Hodge, M.R., Rooney, J.W., and Glimcher, L.H. (1995). The proximalD10 transfectants (5 3 104) were stimulated with APC in the presence
promoter of the IL-4 gene is composed of multiple essential regula-or absence of antigen for 18 hr. Then 1 mCi [3H]thymidine was added
tory sites that bind at least two distinct factors. J. Immunol. 154,to the culture and allowed to be incorporated into the cells. After
6397±6405.another 18 hr incubation, the cells were harvested and [3H]thymidine
Hodge, M.R., Chun, H.J., Rengarajan, J., Alt, A., Lieberson, R.,incorporation was measured on a b counter (Beckman). Triplicates
Glimcher, L.H. (1996). NF-AT-driven interleukin-4 transcription po-of each sample were measured and averages determined.
tentiated by NIP45. Science 274, 1903±1906.
Hou, J., Schindler, U., Henzel, W.J., Ho, T.C., Brasseur, M., andLuciferase Assay
McKnight, S.L. (1994). An interleukin-4-induced transcription factor:One dayafter transfection, M12 cellswere either treated or untreated
IL-4 Stat. Science 265, 1701±1706.with 50 ng/ml PMA plus 1 mM ionomycin for 18±24 hr. Cell extracts
Hsieh, C.S., Macatonia, S.E., Tripp, C.S., Wolf, S.F., O'Garra, A.,were prepared using the Luciferase Assay Kit (Promega). Equal
Murphy, K.M., Wynn, T.A., Jankovic, D., Hieny, S., Zioncheck, K., etamounts of extract protein were used for luciferase activity assay
al. (1993). Development of TH1 CD41 T cells through IL-12 producedand the relative light units were measured in a luminometer (Lumat).
by Listeria-induced macrophages. Science 260, 547±549.Background was subtracted from the readings and fold induction
of luciferase activity was calculated as compared with the unstimu- Hubank, M., and Schatz, D. (1994). Identifying difference in mRNA
lated cells. expression by representational difference analysis of cDNA. Nucleic
Acids Res. 22, 5640±5648.
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